The CRISPR Revolution Reaches Canadian Farms
Gene editing is fundamentally different from traditional genetic engineering. Instead of inserting foreign DNA from another species, CRISPR and similar tools make precise cuts in a plant’s own DNA and let the cell repair the break in a desired way. This can disable a gene that causes disease or susceptibility, or enhance beneficial traits.
For regulators and consumers, the distinction matters enormously. A gene-edited crop might be visually and molecularly identical to a plant that could theoretically arise through conventional breeding, yet it was created in a few months in a lab instead of decades of crossing.
How CRISPR Differs from Traditional GMO
Traditional GMO crops contain inserted DNA from a different organism. Roundup Ready soya carries the CP4 EPSPS gene from Agrobacterium tumefaciens. Bt corn has Cry genes from Bacillus thuringiensis. These insertions are the defining feature of a GMO under most regulatory definitions.
Gene-edited crops created with CRISPR/Cas9 might contain no foreign DNA at all. If the editing machinery is removed after making the cut, the only change is the intended mutation – often a deletion or small insertion in the target plant’s own genome. From a molecular standpoint, this edit is indistinguishable from a rare spontaneous mutation or a breeding-derived change.
Canada’s Regulatory Framework for Gene-Edited Crops
The Canadian Food Inspection Agency (CFIA) regulates novel plant traits. In 2020, CFIA issued guidance clarifying that plants edited with modern molecular techniques but containing no foreign DNA or gene constructs fall outside the definition of plants with novel traits under the Seeds Act.
In practice, this means a CRISPR-edited canola with no Cas9 gene present and no vector DNA remaining does not require CFIA approval before cultivation or sale. The trait itself is assessed, but the editing method is not the regulatory trigger.
This contrasts sharply with the US and EU, where the regulatory status of gene editing remains unsettled. The US generally does not regulate gene-edited crops, while the EU classifies them as GMOs subject to strict approval and labeling.
Gene-Edited Crops Already in Canada and Coming Soon
Calyxt’s gene-edited soybean with enhanced omega-3 fatty acid content has been approved for cultivation and food use in Canada. Other edited traits in development or recently approved include drought-tolerant wheat, virus-resistant papaya, and fungal-disease-resistant wheat.
Many of these traits target crop improvement (yield, nutrition, disease resistance) rather than herbicide or insect resistance. In contrast to first-generation GMOs, gene editing often focuses on agronomic resilience and climate adaptation.
The Detection Challenge: Why Testing Gene-Edited Crops Is Hard
Lateral flow immunoassays and PCR tests targeting foreign proteins or inserted genes are useless for gene-edited crops with no foreign DNA. You cannot detect something that isn’t there.
Testing gene-edited crops requires sequencing or targeted PCR for the specific edit itself. If an edit is a precise deletion of 5 base pairs in a disease resistance gene, you need to sequence or amplify that region and look for the absence of those 5 bases. Different edits require different assays.
This creates a fundamental asymmetry: traditional GMO testing is quick and universal (look for foreign DNA), while gene-edited testing is slow and product-specific (look for the intended mutation).
Practical Implications for Canadian Agriculture and Food Supply
Canadian grain elevators and food manufacturers have no legal obligation to test for or label gene-edited crops. Unlike the US where non-GMO Project verification implies absence of traditional GMOs, Canada has no mandatory labeling framework for either GMOs or gene-edited crops beyond voluntary standards.
However, export markets matter. If Canadian wheat containing an edited trait enters a market requiring GMO labeling (EU, Japan), and that market defines gene editing as requiring disclosure, then Canadian exporters need documentation or testing to comply.
Immunomart continues to expand detection capabilities including options for novel trait identification in cases where specific edits are targeted or where customers require advanced molecular approaches beyond standard lateral flow strips.
The Future: Coexistence of Testing Technologies
As gene-edited crops occupy more acreage, testing will fragment into different approaches. Traditional GMOs will remain detectable by affordable, rapid lateral flow methods. Gene-edited crops will require more sophisticated and crop-specific methods, or will rely on identity preservation and documentation systems rather than end-product testing.
For Canadian farmers and grain traders, understanding the distinction between traditional GMOs (detectable, regulated under Seeds Act) and gene-edited crops (largely unregulated domestically, undetectable by conventional methods) is essential for supply chain planning and export compliance.
Gene editing represents the next chapter in agricultural biotechnology. Whether it becomes widely adopted in Canada will depend on regulatory clarity, market acceptance, and whether the agronomic benefits outweigh the investment in trait development and testing infrastructure.
